Envestnet Asset Management’s ROBO Global Healthcare Technology and Innovation ETF HTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,418
Closed -$281K 4014
2023
Q1
$281K Sell
9,418
-534
-5% -$16.1K ﹤0.01% 3475
2022
Q4
$287K Sell
9,952
-30
-0.3% -$857 ﹤0.01% 3455
2022
Q3
$270K Buy
9,982
+1,206
+14% +$36.9K ﹤0.01% 3413
2022
Q2
$254K Sell
8,776
-310
-3% -$9.6K ﹤0.01% 3455
2022
Q1
$331K Buy
9,086
+757
+9% +$28K ﹤0.01% 3394
2021
Q4
$363K Sell
8,329
-1,289
-13% -$57.6K ﹤0.01% 3289
2021
Q3
$438K Sell
9,618
-535
-5% -$25.5K ﹤0.01% 3044
2021
Q2
$489K Buy
+10,153
New +$461K ﹤0.01% 2999

Other funds holding HTEC

Envestnet Asset Management's HTEC Position: Q2 2023 in Review

Envestnet Asset Management sold out of ROBO Global Healthcare Technology and Innovation ETF (HTEC) in Q2 2023, closing a stake of 9,418 shares — an estimated $281K sold.

Envestnet Asset Management first reported a position in HTEC in Q2 2021 and held it in 8 quarters. The position peaked at $489K in Q2 2021. 35 funds tracked by Wall St. Rank hold HTEC as of Q2 2023.

  • Envestnet Asset Management reported no remaining ROBO Global Healthcare Technology and Innovation ETF position as of Q2 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 9,418 ROBO Global Healthcare Technology and Innovation ETF shares in Q2 2023, an estimated $281K.
  • Envestnet Asset Management first reported a position in ROBO Global Healthcare Technology and Innovation ETF in Q2 2021 and held it in 8 quarters.
  • Envestnet Asset Management's ROBO Global Healthcare Technology and Innovation ETF position peaked at $489K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held ROBO Global Healthcare Technology and Innovation ETF as of Q2 2023.

Based on Envestnet Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.